Invus Global Management, LLC Insider Profile
4 Followers
Invus Global Management, LLC, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 10.83M shares in Scholar Rock Holding (Ticker: SRRK), holds 42.61M shares in Lexicon Pharmaceuticals (Ticker: LXRX). Most recently, Invus Global Management, LLC Bought ― shares of Scholar Rock Holding on Feb 06, 2026 for an estimated value of $11.58M.
Invus Global Management, LLC Lexicon Pharmaceuticals (LXRX)Director, Ten Percent Owner
Lexicon Pharmaceuticals (LXRX)
Director, Ten Percent Owner
Ranked #54,478 out of 105,819 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-1.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Invus Global Management, LLC holds in companies
Most Profitable Insider Trade
The most profitable trade made by Invus Global Management, LLC
Invus Global Management, LLC's Trading History
Lexicon Pharmaceuticals
Feb 04, 2026
Director, Ten Percent Owner
Uninformative Buy
52.98M
$52.41M
Scholar Rock Holding
Feb 06, 2026
Ten Percent Owner
Informative Buy
11.58M
$515.49M
List of latest transactions for each holding click on a transaction to see Invus Global Management, LLC's performance on stock
You May Also Like
Invus Global Management, LLC insider profile FAQ
What is the percentage of profitable transactions made by Invus Global Management, LLC?
The percentage of profitable transactions made by Invus Global Management, LLC is 0%.
What is the average return per transaction made by Invus Global Management, LLC?
The average return per transaction made by Invus Global Management, LLC is -1.50%.
What stocks does Invus Global Management, LLC hold?
Invus Global Management, LLC holds: LXRX, SRRK stocks.
What was Invus Global Management, LLC’s latest transaction?
Invus Global Management, LLC latest transaction was an Informative Buy of $11.58M.
What was Invus Global Management, LLC's most profitable transaction?
Invus Global Management, LLC’s most profitable transaction was an Informative Buy of SRRK stock on February 6, 2026. The return on the trade was 0.00%.
What is Invus Global Management, LLC's role in Lexicon Pharmaceuticals?
Invus Global Management, LLC's role in Lexicon Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.